<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01327651</url>
  </required_header>
  <id_info>
    <org_study_id>HPTN 067 (ADAPT)</org_study_id>
    <secondary_id>10852</secondary_id>
    <nct_id>NCT01327651</nct_id>
  </id_info>
  <brief_title>The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)</brief_title>
  <acronym>ADAPT</acronym>
  <official_title>The ADAPT Study: A Phase II, Randomized, Open-Label, Pharmacokinetic and Behavioral Study of the Use of Intermittent Oral Emtricitabine/Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis (PrEP) Pre-Exposure Prophylaxis (PrEP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HIV Prevention Trials Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HIV Prevention Trials Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-exposure prophylaxis (PrEP) is a method of preventing HIV infection through the use of
      antiretroviral (ARV) medications before exposure to HIV. This study will examine the
      feasibility of different methods of dosing for a PrEP regimen. Three methods of delivery will
      be compared: daily, time-based, and event-based.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      No single strategy for the prevention of HIV has emerged as consistently used and successful,
      so multiple strategies have been developed. PrEP involves delivering ARV medications to
      people before they are exposed to HIV, in order to prevent infection. The optimal method of
      delivering PrEP has not yet been determined. This study will examine the feasibility of
      delivering PrEP in three methods. Daily dosing involves receiving ARV medications every day;
      time-driven dosing involves receiving ARV medications twice weekly plus a post-exposure dose;
      and event-driven dosing involves receiving ARV medications before and after a potential
      exposure to HIV. The ARV medication that will be used in this study is a combination pill
      that contains emtricitabine and tenofovir disoproxil fumarate (FTC/TDF). Recent research
      studies have shown that, if taken consistently, a daily oral dose of FTC/TDF can reduce the
      risk of HIV infection.

      This study will enroll HIV-uninfected men who have sex with men and transgender women
      (MSM/TGW) and women who have sex with men (WSM). Participation will last 34 weeks. All
      participants will be given a combination pill that contains FTC/TDF. For the first 5 weeks,
      all participants will come to the study clinic weekly to receive a single dose of FTC/TDF.

      At Week 6, participants will be randomly assigned to one of three groups. In the daily dosing
      group, participants will take FTC/TDF once a day. In the time-dosing group, participants will
      take FTC/TDF twice per week and another dose after sexual intercourse (a post-exposure dose).
      In the event-dosing group, participants will take FTC/TDF before and after sexual
      intercourse. During this part of the study, participants will be given FTC/TDF to take on
      their own. Every week, from Week 6 to Week 29, study officials will call to ask questions
      about how many pills participants have taken and when they have had sexual intercourse.
      Participants will also complete computer-assisted self-interviews (CASIs).

      Study visits will occur at enrollment, once a week for the first 5 weeks, and then once a
      month until Week 34. Assessment will include recording of medical history, completing an
      interview about sexual practices and background, and collection of blood, urine, and hair
      samples. Select study visits will include vaginal practices assessment (including use of
      lubricants and vaginal cleansing practices), family planning assessments (for women), and sex
      hormones assessments (for men).

      Participants who acquire HIV infection during the study will discontinue study product. These
      participants will continue to be followed after enrollment at Weeks 4, 6, 10, 14, 18, 22, 26,
      30, and every 12 weeks thereafter, as appropriate, until the last study participant completes
      follow-up at the study site. Participants whose first reactive HIV rapid test is at Week 34
      who are later confirmed to be HIV infected will also be followed every 12 weeks after their
      Week 30 visit until the last study participant completes follow-up at the study site.
      Participants who acquire HIV infection during the study will undergo select protocol
      procedures and will receive counseling and referrals for HIV treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>One arm is daily TDF/FTC. One arm is twice weekly TDF/FTC with a post-exposure dose. One arm is as needed TDF/FTC with a post-exposure dose.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Sexual Exposures Covered by Pre- and Post-exposure Dosing</measure>
    <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
    <description>Coverage will be determined based on the adjusted electronic and self-reported pill-use data. Specifically, a sex act will be considered as &quot;covered&quot; if at least one pill is taken 96 hours prior the sexual activity and at least one additional pill is taken within 24 hours after the sexual activity. If participant only took pill before the sexual activity (within 96 hours), but no pill taken after sexual activity (within 24 hours), then we considered it as pre-exposure covered. likewise, if participant only took pill after sexual activity (within 24 hours), but did not taken pill before sexual activity (within 96 hours), then we considered it as post-exposure covered. If participant did not taken pill before and after sexual activity, then it was considered as not covered. Note that the same pill can be both pre-exposure dose and a post-exposure dose if events are closely spaced. At no time should a participant in the intermittent arm be taking more pills than the daily arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The (Minimum) Total Number of Pills Needed for 100% Coverage Over the Follow-up Period (Based on Randomization Arm and Self-reported Sexual History in the Weekly Interviews)</measure>
    <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
    <description>Below I reported the number of sex acts as reported based on the adjusted electronic and self-reported sexual activity data, also the number of pills needed for 100% coverage. 100% coverage means all sex events (excluding oral sex) are &quot;covered&quot;; Note: sex act is considered as &quot;covered&quot; if at least one pill is taken 96 hours prior the sexual activity and at least one additional pill is taken within 24 hours after the sexual activity (same coverage definition for all three arms)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Total Pills Actually Used Over the Follow-up Period</measure>
    <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
    <description>The total pills actually used over the follow-up period was calculated based on the adjusted electronic and self-reported pill-use data. It could be more or less than required by study design</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-reported Side Effect or Symptom Scores</measure>
    <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
    <description>The self-reported symptom/side effect scores for common symptoms/side effects including headache, dizziness, cramping, abdominal pain, and flatulence. Collected during clinic visits. All the presented numbers are the percent of visits with each side effects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of TFV-DP (Tenofovir Diphosphate) in PBMC (Peripheral Blood Mononuclear Cell)</measure>
    <time_frame>week 10, 18 and 30, which is 4 weeks, 12 weeks, and 24 weeks after randomization</time_frame>
    <description>Below we presented the percentages of total cohort with TFV-DP concentrations consistent with &gt;=2 pills/week in women who also report sex in the last 7 day for each arm. For Cape Town and Bangkok, TFV-DP in PBMC was analyzed, for Harlem site, the TFV-DP in DBS (dried blood spot) was analyzed. Note: PBMC &gt;5.2 fmol/10^6 cells is considered as participants taken &gt;=2 tablets per week; DBS &gt;=326 fmol/punch is considered as participants taken &gt;=2 tablets per week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A Listing of Adverse Events (AEs) by Grade, Relationship to Study Product, and Arm</measure>
    <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
    <description>Only the listing of adverse events (AEs) by grade and arm are presented here. See outcome measure 10 for the listing of AE by relationship to study product</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</measure>
    <time_frame>From enrollment to week 30 (end of self-administered dosing)</time_frame>
    <description>Only the cross table between drug resistance by arm are presented here. See outcome measure 11 for the listing of plasma HIV RNA levels, and outcome measure 12 for the listing of drug resistance test by arm among all participants who seroconvert while on study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Percentage of Correctly Timed Adherence (Number of Pills Taken Within the Recommended Time Frame/Number of Pills Recommended) During 24 Weeks of Follow-up Based on Weekly Interviews and Adjusted EDM (Electronic Drug Monitoring) Data</measure>
    <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Proportion of Participants Who Discontinue All PrEP Use Based on Self-report Via CASI or Weekly Interviews</measure>
    <time_frame>From Week 6 to Week 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A Listing of Adverse Events (AEs) by Grade, Relationship to Study Product, and Arm</measure>
    <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
    <description>Only the listing of AE related to study product are presented here. See outcome measure 6 for the listing of adverse events (AEs) by grade and arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</measure>
    <time_frame>From Enrollment to week 30 (end of self-administered dosing)</time_frame>
    <description>Only the listing of plasma HIV RNA levels among all participants who seroconvert while on study are presented here. See outcome measure 12 for the listing of drug resistance test by arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</measure>
    <time_frame>From Enrollment to week 30 (end of self-administered dosing)</time_frame>
    <description>Only the listing of drug resistance test by arm among all participants who seroconvert while on study are presented here. See outcome measure 11 for the listing of plasma HIV RNA levels</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">622</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Daily dosing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive oral FTC/TDF daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Time-driven dosing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive oral FTC/TDF twice weekly with a post-exposure dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Event-driven dosing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Daily dosing</intervention_name>
    <description>A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate.</description>
    <arm_group_label>Daily dosing</arm_group_label>
    <other_name>Daily</other_name>
    <other_name>TDF/FTC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Time-driven dosing</intervention_name>
    <description>TDF/FTC twice weekly with a post-exposure dose</description>
    <arm_group_label>Time-driven dosing</arm_group_label>
    <other_name>A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Event-driven dosing</intervention_name>
    <description>TDF/FTC as needed with a post exposure dose</description>
    <arm_group_label>Event-driven dosing</arm_group_label>
    <other_name>A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Literacy in one of the study languages (Thai, Xhosa, and/or English)

          -  Able to provide written informed consent

          -  Able to provide weekly telephonic updates

          -  Within 70 days of enrollment:

               1. Serum creatinine less than or equal to the upper limit of normal (ULN) and
                  calculated creatinine clearance of at least 70 mL/min by the Cockcroft-Gault
                  formula. More information on this criterion can be found in the protocol.

               2. Serum phosphate greater than or equal to the lower limit of normal (LLN)

               3. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) less than or
                  equal to 2 times ULN

               4. Hemoglobin greater than 10 g/dL

               5. Hepatitis B surface antigen (HBsAg)-negative

               6. Willing and able to provide adequate locator information

        Inclusion Criteria for MSM/TGW:

          -  Male at birth

          -  Reporting anal intercourse and/or receptive neovaginal intercourse with at least one
             man or transgender woman in the past 6 months

          -  One or more of the following risk factors for HIV acquisition in the past 6 months
             according to self-report: sexual intercourse with more than one man or transgender
             woman; history of an acute sexually transmitted infection (STI); sex in exchange for
             money, goods, or favors; condomless intercourse (oral, anal, vaginal, or neovaginal)
             with a partner known to be HIV-infected or of unknown HIV infection status according
             to self report

        Inclusion Criteria for Women Who Have Sex With Men (WSM):

          -  Female at birth or self identify as female

          -  Not pregnant or breastfeeding

          -  Not able to or not intending to become pregnant during the next year

          -  If able to become pregnant, self reported use of an effective method of contraception
             at Enrollment, and intending to use an effective method for the next 34 weeks

          -  One or more of the following risk factors for HIV acquisition in the past 6 months
             according to self report: sexual intercourse with more than one man; history of an
             acute STI; sex in exchange for money, goods or favors; condomless intercourse (oral,
             anal, or vaginal) with a partner known to be HIV-infected or of unknown HIV infection
             status

        Exclusion Criteria:

          -  Proteinuria 2+ or greater at screening

          -  Glucosuria 2+ or greater at screening

          -  Serious and active medical or mental illness

          -  One or both HIV rapid tests is reactive at screening or enrollment, regardless of
             subsequent HIV diagnostic test results

          -  Signs or symptoms suggestive of acute HIV infection

          -  Use of hypoglycemic agents for diabetes or agents with known nephrotoxic potential

          -  Use of ARV therapy (e.g., for post-exposure prophylaxis [PEP] or PrEP) in the 90 days
             prior to study entry

          -  Serum phosphate level below site laboratory LLN

          -  Current participation (or participation within 3 months of screening) in any HIV
             prevention study

          -  Previous or current participation in the active arm of an HIV vaccine trial

          -  Acute or chronic hepatitis B (HBV) infection (refers to chronic active HBV infection
             evidenced by a positive test for hepatitis B surface antigen (HBsAg)

          -  Presence of a psychological or social condition or an addictive disorder that would
             preclude compliance with the protocol

          -  Any other reason or condition that in the opinion of the investigator would interfere
             with participation, complicate interpretation of study outcome data, or otherwise
             interfere with achieving the study objectives
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert M. Grant, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frits van Griensven, PhD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>School of Medicine, University of California at San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harlem Prevention Center CRS</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emavundleni CRS</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape Province</state>
        <zip>7750</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Silom Community Clinic CRS</name>
      <address>
        <city>Nonthaburi</city>
        <zip>11000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
    <country>Thailand</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.</citation>
    <PMID>21091279</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2011</study_first_posted>
  <results_first_submitted>January 5, 2017</results_first_submitted>
  <results_first_submitted_qc>March 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 12, 2017</results_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drug Administration Schedule</keyword>
  <keyword>Nucleoside Reverse Transcriptase Inhibitors</keyword>
  <keyword>Pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tenofovir</mesh_term>
    <mesh_term>Emtricitabine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study enrolled men, and transgender women, who have sex with men at a community clinic and clinical research site (CRS) in Bangkok, Thailand, and a CRS in Harlem in New York City, USA. Women were enrolled at a study site in Cape Town, South Africa. The last participant was enrolled in May of 2014</recruitment_details>
      <pre_assignment_details>Of the 902 screened participants, 622 were eligible to be enrolled into the study, and participated in a 6-week lead-in period of directly observed dosing (DOD) of one tablet once-weekly of FTC/TDF for five observed doses followed by 1-week off drug. 86% (N=536) completed the lead-in period and were randomized to the three arms.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Daily Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF daily. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="P2">
          <title>Time-driven Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="P3">
          <title>Event-driven Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="P4">
          <title>Daily Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF daily. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="P5">
          <title>Time-driven Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors</description>
        </group>
        <group group_id="P6">
          <title>Event-driven Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="P7">
          <title>Daily Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF daily. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="P8">
          <title>Time-driven Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="P9">
          <title>Event-driven Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Self-administered Dosing Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="59"/>
                <participants group_id="P3" count="60"/>
                <participants group_id="P4" count="60"/>
                <participants group_id="P5" count="59"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="59"/>
                <participants group_id="P8" count="60"/>
                <participants group_id="P9" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 10</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="58"/>
                <participants group_id="P3" count="60"/>
                <participants group_id="P4" count="60"/>
                <participants group_id="P5" count="59"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="57"/>
                <participants group_id="P8" count="57"/>
                <participants group_id="P9" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 14</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="55"/>
                <participants group_id="P3" count="57"/>
                <participants group_id="P4" count="60"/>
                <participants group_id="P5" count="58"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="54"/>
                <participants group_id="P8" count="51"/>
                <participants group_id="P9" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 18</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="56"/>
                <participants group_id="P4" count="60"/>
                <participants group_id="P5" count="57"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="53"/>
                <participants group_id="P8" count="49"/>
                <participants group_id="P9" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 22</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="55"/>
                <participants group_id="P4" count="58"/>
                <participants group_id="P5" count="56"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="50"/>
                <participants group_id="P8" count="50"/>
                <participants group_id="P9" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 26</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="53"/>
                <participants group_id="P4" count="57"/>
                <participants group_id="P5" count="56"/>
                <participants group_id="P6" count="58"/>
                <participants group_id="P7" count="50"/>
                <participants group_id="P8" count="51"/>
                <participants group_id="P9" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="56"/>
                <participants group_id="P4" count="57"/>
                <participants group_id="P5" count="56"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="49"/>
                <participants group_id="P8" count="50"/>
                <participants group_id="P9" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="10"/>
                <participants group_id="P8" count="10"/>
                <participants group_id="P9" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="8"/>
                <participants group_id="P8" count="9"/>
                <participants group_id="P9" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Ineligible (retrospective result)</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Post Study Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="56"/>
                <participants group_id="P4" count="57"/>
                <participants group_id="P5" count="56"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="49"/>
                <participants group_id="P8" count="50"/>
                <participants group_id="P9" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="55"/>
                <participants group_id="P3" count="55"/>
                <participants group_id="P4" count="57"/>
                <participants group_id="P5" count="56"/>
                <participants group_id="P6" count="59"/>
                <participants group_id="P7" count="45"/>
                <participants group_id="P8" count="49"/>
                <participants group_id="P9" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="4"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="4"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>For daily dosing arm in Cape Town, we dropped one participant from analysis, since retrospective test of HIV infection in central lab shows that this participant was seroconverted on week 6(randomization week), so she was not eligible to be randomized. Because of this, total baseline population dropped from 536 to 535.</population>
      <group_list>
        <group group_id="B1">
          <title>Daily Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B2">
          <title>Time-driven Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B3">
          <title>Event-driven Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B4">
          <title>Daily Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B5">
          <title>Time-driven Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B6">
          <title>Event-driven Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B7">
          <title>Daily Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B8">
          <title>Time-driven Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B9">
          <title>Event-driven Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="B10">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="59"/>
            <count group_id="B2" value="59"/>
            <count group_id="B3" value="60"/>
            <count group_id="B4" value="60"/>
            <count group_id="B5" value="59"/>
            <count group_id="B6" value="59"/>
            <count group_id="B7" value="59"/>
            <count group_id="B8" value="60"/>
            <count group_id="B9" value="60"/>
            <count group_id="B10" value="535"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" lower_limit="21" upper_limit="37"/>
                    <measurement group_id="B2" value="26" lower_limit="21" upper_limit="33"/>
                    <measurement group_id="B3" value="25" lower_limit="21" upper_limit="37"/>
                    <measurement group_id="B4" value="31" lower_limit="28" upper_limit="34"/>
                    <measurement group_id="B5" value="28" lower_limit="25" upper_limit="35"/>
                    <measurement group_id="B6" value="31" lower_limit="27" upper_limit="34"/>
                    <measurement group_id="B7" value="28" lower_limit="23" upper_limit="43"/>
                    <measurement group_id="B8" value="31" lower_limit="24" upper_limit="41"/>
                    <measurement group_id="B9" value="32" lower_limit="24" upper_limit="46"/>
                    <measurement group_id="B10" value="29" lower_limit="24" upper_limit="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>18-24 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="8"/>
                    <measurement group_id="B7" value="19"/>
                    <measurement group_id="B8" value="17"/>
                    <measurement group_id="B9" value="17"/>
                    <measurement group_id="B10" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>25-29 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="19"/>
                    <measurement group_id="B6" value="16"/>
                    <measurement group_id="B7" value="13"/>
                    <measurement group_id="B8" value="11"/>
                    <measurement group_id="B9" value="8"/>
                    <measurement group_id="B10" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30-39 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="36"/>
                    <measurement group_id="B5" value="23"/>
                    <measurement group_id="B6" value="28"/>
                    <measurement group_id="B7" value="11"/>
                    <measurement group_id="B8" value="12"/>
                    <measurement group_id="B9" value="14"/>
                    <measurement group_id="B10" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40+ years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="16"/>
                    <measurement group_id="B8" value="20"/>
                    <measurement group_id="B9" value="21"/>
                    <measurement group_id="B10" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="60"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="59"/>
                    <measurement group_id="B5" value="58"/>
                    <measurement group_id="B6" value="59"/>
                    <measurement group_id="B7" value="57"/>
                    <measurement group_id="B8" value="59"/>
                    <measurement group_id="B9" value="58"/>
                    <measurement group_id="B10" value="350"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Transgender woman</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gender queer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Less than secondary</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="16"/>
                    <measurement group_id="B8" value="18"/>
                    <measurement group_id="B9" value="7"/>
                    <measurement group_id="B10" value="159"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Secondary and above</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="60"/>
                    <measurement group_id="B5" value="58"/>
                    <measurement group_id="B6" value="58"/>
                    <measurement group_id="B7" value="43"/>
                    <measurement group_id="B8" value="42"/>
                    <measurement group_id="B9" value="53"/>
                    <measurement group_id="B10" value="376"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of sex partners in the past 3 months</title>
          <description>Median number of sex partners in the past 3 months, measured at baseline</description>
          <units>sex partners</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="B2" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="B3" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="B4" value="3" lower_limit="2" upper_limit="10"/>
                    <measurement group_id="B5" value="3" lower_limit="1" upper_limit="10"/>
                    <measurement group_id="B6" value="3" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="B7" value="3" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="B8" value="3" lower_limit="2" upper_limit="6"/>
                    <measurement group_id="B9" value="4" lower_limit="2" upper_limit="7"/>
                    <measurement group_id="B10" value="2" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of anal intercourse without a condom</title>
          <units>anal intercourse</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" lower_limit="0" upper_limit="7"/>
                    <measurement group_id="B2" value="2" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="B3" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="B4" value="0" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="B5" value="0" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="B6" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B7" value="3" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="B8" value="3" lower_limit="1" upper_limit="10"/>
                    <measurement group_id="B9" value="5" lower_limit="1" upper_limit="9"/>
                    <measurement group_id="B10" value="1" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Sexual Exposures Covered by Pre- and Post-exposure Dosing</title>
        <description>Coverage will be determined based on the adjusted electronic and self-reported pill-use data. Specifically, a sex act will be considered as “covered” if at least one pill is taken 96 hours prior the sexual activity and at least one additional pill is taken within 24 hours after the sexual activity. If participant only took pill before the sexual activity (within 96 hours), but no pill taken after sexual activity (within 24 hours), then we considered it as pre-exposure covered. likewise, if participant only took pill after sexual activity (within 24 hours), but did not taken pill before sexual activity (within 96 hours), then we considered it as post-exposure covered. If participant did not taken pill before and after sexual activity, then it was considered as not covered. Note that the same pill can be both pre-exposure dose and a post-exposure dose if events are closely spaced. At no time should a participant in the intermittent arm be taking more pills than the daily arm.</description>
        <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
        <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Sexual Exposures Covered by Pre- and Post-exposure Dosing</title>
          <description>Coverage will be determined based on the adjusted electronic and self-reported pill-use data. Specifically, a sex act will be considered as “covered” if at least one pill is taken 96 hours prior the sexual activity and at least one additional pill is taken within 24 hours after the sexual activity. If participant only took pill before the sexual activity (within 96 hours), but no pill taken after sexual activity (within 24 hours), then we considered it as pre-exposure covered. likewise, if participant only took pill after sexual activity (within 24 hours), but did not taken pill before sexual activity (within 96 hours), then we considered it as post-exposure covered. If participant did not taken pill before and after sexual activity, then it was considered as not covered. Note that the same pill can be both pre-exposure dose and a post-exposure dose if events are closely spaced. At no time should a participant in the intermittent arm be taking more pills than the daily arm.</description>
          <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
          <units>percentage of sexual exposures</units>
          <param>Number</param>
          <units_analyzed>sexual exposures</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>sexual exposures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1952"/>
                <count group_id="O2" value="1074"/>
                <count group_id="O3" value="1542"/>
                <count group_id="O4" value="1485"/>
                <count group_id="O5" value="1337"/>
                <count group_id="O6" value="1018"/>
                <count group_id="O7" value="1081"/>
                <count group_id="O8" value="1311"/>
                <count group_id="O9" value="1502"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>% completely covered</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="52"/>
                    <measurement group_id="O4" value="85"/>
                    <measurement group_id="O5" value="84"/>
                    <measurement group_id="O6" value="74"/>
                    <measurement group_id="O7" value="66"/>
                    <measurement group_id="O8" value="47"/>
                    <measurement group_id="O9" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% pre-exposure coverage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="33"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="19"/>
                    <measurement group_id="O7" value="24"/>
                    <measurement group_id="O8" value="30"/>
                    <measurement group_id="O9" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% post-exposure coverage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="8"/>
                    <measurement group_id="O9" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% uncovered</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The (Minimum) Total Number of Pills Needed for 100% Coverage Over the Follow-up Period (Based on Randomization Arm and Self-reported Sexual History in the Weekly Interviews)</title>
        <description>Below I reported the number of sex acts as reported based on the adjusted electronic and self-reported sexual activity data, also the number of pills needed for 100% coverage. 100% coverage means all sex events (excluding oral sex) are “covered”; Note: sex act is considered as “covered” if at least one pill is taken 96 hours prior the sexual activity and at least one additional pill is taken within 24 hours after the sexual activity (same coverage definition for all three arms)</description>
        <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
        <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>The (Minimum) Total Number of Pills Needed for 100% Coverage Over the Follow-up Period (Based on Randomization Arm and Self-reported Sexual History in the Weekly Interviews)</title>
          <description>Below I reported the number of sex acts as reported based on the adjusted electronic and self-reported sexual activity data, also the number of pills needed for 100% coverage. 100% coverage means all sex events (excluding oral sex) are “covered”; Note: sex act is considered as “covered” if at least one pill is taken 96 hours prior the sexual activity and at least one additional pill is taken within 24 hours after the sexual activity (same coverage definition for all three arms)</description>
          <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
          <units>Number of pills needed for 100% coverage</units>
          <param>Number</param>
          <units_analyzed>sexual exposure</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>sexual exposure</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1952"/>
                <count group_id="O2" value="1074"/>
                <count group_id="O3" value="1542"/>
                <count group_id="O4" value="1485"/>
                <count group_id="O5" value="1337"/>
                <count group_id="O6" value="1018"/>
                <count group_id="O7" value="1081"/>
                <count group_id="O8" value="1311"/>
                <count group_id="O9" value="1502"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2097"/>
                    <measurement group_id="O2" value="1552"/>
                    <measurement group_id="O3" value="1906"/>
                    <measurement group_id="O4" value="1746"/>
                    <measurement group_id="O5" value="1573"/>
                    <measurement group_id="O6" value="1268"/>
                    <measurement group_id="O7" value="1244"/>
                    <measurement group_id="O8" value="1390"/>
                    <measurement group_id="O9" value="1582"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Total Pills Actually Used Over the Follow-up Period</title>
        <description>The total pills actually used over the follow-up period was calculated based on the adjusted electronic and self-reported pill-use data. It could be more or less than required by study design</description>
        <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
        <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>The Total Pills Actually Used Over the Follow-up Period</title>
          <description>The total pills actually used over the follow-up period was calculated based on the adjusted electronic and self-reported pill-use data. It could be more or less than required by study design</description>
          <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
          <units>Number of pills actually used</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7349"/>
                    <measurement group_id="O2" value="2852"/>
                    <measurement group_id="O3" value="2000"/>
                    <measurement group_id="O4" value="8285"/>
                    <measurement group_id="O5" value="3713"/>
                    <measurement group_id="O6" value="2157"/>
                    <measurement group_id="O7" value="5507"/>
                    <measurement group_id="O8" value="2468"/>
                    <measurement group_id="O9" value="2356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Self-reported Side Effect or Symptom Scores</title>
        <description>The self-reported symptom/side effect scores for common symptoms/side effects including headache, dizziness, cramping, abdominal pain, and flatulence. Collected during clinic visits. All the presented numbers are the percent of visits with each side effects</description>
        <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
        <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>Self-reported Side Effect or Symptom Scores</title>
          <description>The self-reported symptom/side effect scores for common symptoms/side effects including headache, dizziness, cramping, abdominal pain, and flatulence. Collected during clinic visits. All the presented numbers are the percent of visits with each side effects</description>
          <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
          <units>percent of visits between week 6 to 30</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Neurologic side effect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.4"/>
                    <measurement group_id="O2" value="6.0"/>
                    <measurement group_id="O3" value="7.8"/>
                    <measurement group_id="O4" value="14.2"/>
                    <measurement group_id="O5" value="14.3"/>
                    <measurement group_id="O6" value="13.3"/>
                    <measurement group_id="O7" value="6.1"/>
                    <measurement group_id="O8" value="3.3"/>
                    <measurement group_id="O9" value="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gastrointestinal side effects</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.6"/>
                    <measurement group_id="O2" value="8.8"/>
                    <measurement group_id="O3" value="5.4"/>
                    <measurement group_id="O4" value="13.1"/>
                    <measurement group_id="O5" value="8.5"/>
                    <measurement group_id="O6" value="10.5"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="5.8"/>
                    <measurement group_id="O9" value="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measurement of TFV-DP (Tenofovir Diphosphate) in PBMC (Peripheral Blood Mononuclear Cell)</title>
        <description>Below we presented the percentages of total cohort with TFV-DP concentrations consistent with &gt;=2 pills/week in women who also report sex in the last 7 day for each arm. For Cape Town and Bangkok, TFV-DP in PBMC was analyzed, for Harlem site, the TFV-DP in DBS (dried blood spot) was analyzed. Note: PBMC &gt;5.2 fmol/10^6 cells is considered as participants taken &gt;=2 tablets per week; DBS &gt;=326 fmol/punch is considered as participants taken &gt;=2 tablets per week</description>
        <time_frame>week 10, 18 and 30, which is 4 weeks, 12 weeks, and 24 weeks after randomization</time_frame>
        <population>Note: Not all participants were available to be analyzed at each visits below, this could be due to missed visit, drug concentration was missing, or participants did not report to have any sex in the last 7 days</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of TFV-DP (Tenofovir Diphosphate) in PBMC (Peripheral Blood Mononuclear Cell)</title>
          <description>Below we presented the percentages of total cohort with TFV-DP concentrations consistent with &gt;=2 pills/week in women who also report sex in the last 7 day for each arm. For Cape Town and Bangkok, TFV-DP in PBMC was analyzed, for Harlem site, the TFV-DP in DBS (dried blood spot) was analyzed. Note: PBMC &gt;5.2 fmol/10^6 cells is considered as participants taken &gt;=2 tablets per week; DBS &gt;=326 fmol/punch is considered as participants taken &gt;=2 tablets per week</description>
          <population>Note: Not all participants were available to be analyzed at each visits below, this could be due to missed visit, drug concentration was missing, or participants did not report to have any sex in the last 7 days</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="23"/>
                    <count group_id="O3" value="37"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="29"/>
                    <count group_id="O6" value="30"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="23"/>
                    <count group_id="O9" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="31"/>
                    <measurement group_id="O5" value="29"/>
                    <measurement group_id="O6" value="30"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="8"/>
                    <measurement group_id="O9" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="30"/>
                    <count group_id="O4" value="29"/>
                    <count group_id="O5" value="30"/>
                    <count group_id="O6" value="26"/>
                    <count group_id="O7" value="27"/>
                    <count group_id="O8" value="27"/>
                    <count group_id="O9" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="30"/>
                    <measurement group_id="O6" value="24"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="24"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="23"/>
                    <count group_id="O5" value="19"/>
                    <count group_id="O6" value="14"/>
                    <count group_id="O7" value="18"/>
                    <count group_id="O8" value="18"/>
                    <count group_id="O9" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>A Listing of Adverse Events (AEs) by Grade, Relationship to Study Product, and Arm</title>
        <description>Only the listing of adverse events (AEs) by grade and arm are presented here. See outcome measure 10 for the listing of AE by relationship to study product</description>
        <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>A Listing of Adverse Events (AEs) by Grade, Relationship to Study Product, and Arm</title>
          <description>Only the listing of adverse events (AEs) by grade and arm are presented here. See outcome measure 10 for the listing of AE by relationship to study product</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Blood and lymphatic system disorders : Mild</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="57"/>
                    <measurement group_id="O3" value="59"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="59"/>
                    <measurement group_id="O7" value="57"/>
                    <measurement group_id="O8" value="58"/>
                    <measurement group_id="O9" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardiac disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="59"/>
                    <measurement group_id="O4" value="58"/>
                    <measurement group_id="O5" value="58"/>
                    <measurement group_id="O6" value="58"/>
                    <measurement group_id="O7" value="58"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ear and labyrinth disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="60"/>
                    <measurement group_id="O4" value="59"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="58"/>
                    <measurement group_id="O7" value="58"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eye disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="57"/>
                    <measurement group_id="O3" value="59"/>
                    <measurement group_id="O4" value="59"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="59"/>
                    <measurement group_id="O7" value="57"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gastrointestinal disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="23"/>
                    <measurement group_id="O7" value="28"/>
                    <measurement group_id="O8" value="27"/>
                    <measurement group_id="O9" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="30"/>
                    <measurement group_id="O5" value="35"/>
                    <measurement group_id="O6" value="32"/>
                    <measurement group_id="O7" value="30"/>
                    <measurement group_id="O8" value="31"/>
                    <measurement group_id="O9" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General disorders and administration site conditio</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="16"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="50"/>
                    <measurement group_id="O5" value="43"/>
                    <measurement group_id="O6" value="47"/>
                    <measurement group_id="O7" value="46"/>
                    <measurement group_id="O8" value="49"/>
                    <measurement group_id="O9" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hepatobiliary disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="58"/>
                    <measurement group_id="O3" value="60"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="58"/>
                    <measurement group_id="O6" value="59"/>
                    <measurement group_id="O7" value="59"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Immune system disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="58"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="59"/>
                    <measurement group_id="O7" value="59"/>
                    <measurement group_id="O8" value="59"/>
                    <measurement group_id="O9" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infections and infestations</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="22"/>
                    <measurement group_id="O5" value="33"/>
                    <measurement group_id="O6" value="28"/>
                    <measurement group_id="O7" value="22"/>
                    <measurement group_id="O8" value="21"/>
                    <measurement group_id="O9" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="6"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="27"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="19"/>
                    <measurement group_id="O7" value="37"/>
                    <measurement group_id="O8" value="39"/>
                    <measurement group_id="O9" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injury, poisoning and procedural complications</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="17"/>
                    <measurement group_id="O8" value="18"/>
                    <measurement group_id="O9" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="46"/>
                    <measurement group_id="O4" value="44"/>
                    <measurement group_id="O5" value="41"/>
                    <measurement group_id="O6" value="44"/>
                    <measurement group_id="O7" value="38"/>
                    <measurement group_id="O8" value="41"/>
                    <measurement group_id="O9" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Investigations</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="35"/>
                    <measurement group_id="O5" value="47"/>
                    <measurement group_id="O6" value="48"/>
                    <measurement group_id="O7" value="50"/>
                    <measurement group_id="O8" value="50"/>
                    <measurement group_id="O9" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolism and nutrition disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="49"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="58"/>
                    <measurement group_id="O6" value="58"/>
                    <measurement group_id="O7" value="52"/>
                    <measurement group_id="O8" value="53"/>
                    <measurement group_id="O9" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Musculoskeletal and connective tissue disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="11"/>
                    <measurement group_id="O9" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="43"/>
                    <measurement group_id="O5" value="43"/>
                    <measurement group_id="O6" value="44"/>
                    <measurement group_id="O7" value="46"/>
                    <measurement group_id="O8" value="49"/>
                    <measurement group_id="O9" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nervous system disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="18"/>
                    <measurement group_id="O6" value="22"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="10"/>
                    <measurement group_id="O9" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="29"/>
                    <measurement group_id="O4" value="39"/>
                    <measurement group_id="O5" value="41"/>
                    <measurement group_id="O6" value="36"/>
                    <measurement group_id="O7" value="42"/>
                    <measurement group_id="O8" value="47"/>
                    <measurement group_id="O9" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pregnancy, puerperium and perinatal conditions</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="60"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="59"/>
                    <measurement group_id="O7" value="59"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychiatric disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="56"/>
                    <measurement group_id="O4" value="52"/>
                    <measurement group_id="O5" value="49"/>
                    <measurement group_id="O6" value="51"/>
                    <measurement group_id="O7" value="46"/>
                    <measurement group_id="O8" value="48"/>
                    <measurement group_id="O9" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal and urinary disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="46"/>
                    <measurement group_id="O4" value="59"/>
                    <measurement group_id="O5" value="55"/>
                    <measurement group_id="O6" value="56"/>
                    <measurement group_id="O7" value="47"/>
                    <measurement group_id="O8" value="50"/>
                    <measurement group_id="O9" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reproductive system and breast disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="34"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="57"/>
                    <measurement group_id="O7" value="58"/>
                    <measurement group_id="O8" value="58"/>
                    <measurement group_id="O9" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Respiratory, thoracic and mediastinal disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="36"/>
                    <measurement group_id="O5" value="23"/>
                    <measurement group_id="O6" value="29"/>
                    <measurement group_id="O7" value="18"/>
                    <measurement group_id="O8" value="19"/>
                    <measurement group_id="O9" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="36"/>
                    <measurement group_id="O6" value="29"/>
                    <measurement group_id="O7" value="41"/>
                    <measurement group_id="O8" value="41"/>
                    <measurement group_id="O9" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin and subcutaneous tissue disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="15"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="50"/>
                    <measurement group_id="O5" value="44"/>
                    <measurement group_id="O6" value="46"/>
                    <measurement group_id="O7" value="51"/>
                    <measurement group_id="O8" value="55"/>
                    <measurement group_id="O9" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social circumstances</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="60"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="59"/>
                    <measurement group_id="O7" value="59"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vascular disorders</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                    <measurement group_id="O2" value="55"/>
                    <measurement group_id="O3" value="59"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="58"/>
                    <measurement group_id="O7" value="57"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neoplasms benign, malignant, and unspecified</title>
              <category_list>
                <category>
                  <title>Mild</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Potentically Life Threatening</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Death</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="60"/>
                    <measurement group_id="O4" value="60"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="58"/>
                    <measurement group_id="O7" value="59"/>
                    <measurement group_id="O8" value="60"/>
                    <measurement group_id="O9" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</title>
        <description>Only the cross table between drug resistance by arm are presented here. See outcome measure 11 for the listing of plasma HIV RNA levels, and outcome measure 12 for the listing of drug resistance test by arm among all participants who seroconvert while on study.</description>
        <time_frame>From enrollment to week 30 (end of self-administered dosing)</time_frame>
        <population>Data is collected for plasma HIV RNA levels among all participants who seroconvert while on study, but this secondary analysis has not been carried out yet, so no outcome measure is presented here</population>
        <group_list>
          <group group_id="O1">
            <title>Cape Town, South Africa</title>
            <description>The University of Cape Town in Cape Town is the IRB of record for the Cape Town site</description>
          </group>
          <group group_id="O2">
            <title>Bangkok, Thailand</title>
            <description>The Institutional Review Board, Human Research Protection Office, US Centers for Disease Control and Prevention and the Ethical Review Committee for Research in Human Subjects, Department of Medical Sciences, Ministry of Public Health, Thailand are the IRBs of record for the Bangkok site</description>
          </group>
          <group group_id="O3">
            <title>Harlem, United States</title>
            <description>Columbia University Medical Center Institutional Review Board in New York is the IRB of record for the New York site.</description>
          </group>
        </group_list>
        <measure>
          <title>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</title>
          <description>Only the cross table between drug resistance by arm are presented here. See outcome measure 11 for the listing of plasma HIV RNA levels, and outcome measure 12 for the listing of drug resistance test by arm among all participants who seroconvert while on study.</description>
          <population>Data is collected for plasma HIV RNA levels among all participants who seroconvert while on study, but this secondary analysis has not been carried out yet, so no outcome measure is presented here</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="191"/>
                <count group_id="O2" value="193"/>
                <count group_id="O3" value="238"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Randomization</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="191"/>
                    <count group_id="O2" value="193"/>
                    <count group_id="O3" value="238"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="190"/>
                    <measurement group_id="O2" value="193"/>
                    <measurement group_id="O3" value="237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After Randomization (Daily dosing)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="60"/>
                    <measurement group_id="O3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After Randomization (Time-driven dosing)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After Randomization (Event-driven dosing)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Drug Resistance</title>
                  <measurement_list>
                    <measurement group_id="O1" value="60"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Percentage of Correctly Timed Adherence (Number of Pills Taken Within the Recommended Time Frame/Number of Pills Recommended) During 24 Weeks of Follow-up Based on Weekly Interviews and Adjusted EDM (Electronic Drug Monitoring) Data</title>
        <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
        <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Correctly Timed Adherence (Number of Pills Taken Within the Recommended Time Frame/Number of Pills Recommended) During 24 Weeks of Follow-up Based on Weekly Interviews and Adjusted EDM (Electronic Drug Monitoring) Data</title>
          <population>For Cape Town daily dosing arm, there are originally 60 participants, but 1 participant was later found to be HIV infected on or before randomization visit, which should make this participant not eligible for the study analysis, so we removed this participant from this table. Given this, we left 59 participants in Cape Town daily dosing arm</population>
          <units>% of Correctly Timed Adherence</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="65"/>
                    <measurement group_id="O3" value="53"/>
                    <measurement group_id="O4" value="85"/>
                    <measurement group_id="O5" value="79"/>
                    <measurement group_id="O6" value="65"/>
                    <measurement group_id="O7" value="65"/>
                    <measurement group_id="O8" value="47"/>
                    <measurement group_id="O9" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Proportion of Participants Who Discontinue All PrEP Use Based on Self-report Via CASI or Weekly Interviews</title>
        <time_frame>From Week 6 to Week 30</time_frame>
        <population>Number of participants had product hold or product discontinuation log</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>The Proportion of Participants Who Discontinue All PrEP Use Based on Self-report Via CASI or Weekly Interviews</title>
          <population>Number of participants had product hold or product discontinuation log</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="12"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="5"/>
                <count group_id="O7" value="2"/>
                <count group_id="O8" value="7"/>
                <count group_id="O9" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Pregnancy</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HIV−positive result</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other adverse experience</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>A Listing of Adverse Events (AEs) by Grade, Relationship to Study Product, and Arm</title>
        <description>Only the listing of AE related to study product are presented here. See outcome measure 6 for the listing of adverse events (AEs) by grade and arm.</description>
        <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
        <population>Below &quot;Number analyzed&quot; population only included the participants who had below adverse events, and the number next to it represent the number of participants had the corresponding AE that was related to the study product</population>
        <group_list>
          <group group_id="O1">
            <title>Daily Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O2">
            <title>Time-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O3">
            <title>Event-driven Dosing, Cape Town</title>
            <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O4">
            <title>Daily Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O5">
            <title>Time-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O6">
            <title>Event-driven Dosing, Bangkok</title>
            <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O7">
            <title>Daily Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O8">
            <title>Time-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
          <group group_id="O9">
            <title>Event-driven Dosing, Harlem</title>
            <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
          </group>
        </group_list>
        <measure>
          <title>A Listing of Adverse Events (AEs) by Grade, Relationship to Study Product, and Arm</title>
          <description>Only the listing of AE related to study product are presented here. See outcome measure 6 for the listing of adverse events (AEs) by grade and arm.</description>
          <population>Below &quot;Number analyzed&quot; population only included the participants who had below adverse events, and the number next to it represent the number of participants had the corresponding AE that was related to the study product</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="60"/>
                <count group_id="O4" value="60"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
                <count group_id="O7" value="59"/>
                <count group_id="O8" value="60"/>
                <count group_id="O9" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Blood and lymphatic system disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="2"/>
                    <count group_id="O9" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardiac disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ear and labyrinth disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eye disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gastrointestinal disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="26"/>
                    <count group_id="O2" value="27"/>
                    <count group_id="O3" value="28"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="27"/>
                    <count group_id="O7" value="29"/>
                    <count group_id="O8" value="29"/>
                    <count group_id="O9" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="13"/>
                    <measurement group_id="O9" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General disorders and administration site conditio</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="12"/>
                    <count group_id="O7" value="13"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hepatobiliary disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Immune system disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infections and infestations</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="22"/>
                    <count group_id="O8" value="21"/>
                    <count group_id="O9" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injury, poisoning and procedural complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="16"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="19"/>
                    <count group_id="O9" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="16"/>
                    <measurement group_id="O9" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Investigations</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="21"/>
                    <count group_id="O3" value="17"/>
                    <count group_id="O4" value="25"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="11"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolism and nutrition disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="10"/>
                    <count group_id="O3" value="17"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="7"/>
                    <count group_id="O8" value="7"/>
                    <count group_id="O9" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="5"/>
                    <measurement group_id="O9" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Musculoskeletal and connective tissue disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="8"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="17"/>
                    <count group_id="O5" value="16"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="13"/>
                    <count group_id="O8" value="11"/>
                    <count group_id="O9" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neoplasms benign, malignant, and unspecified</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="60"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nervous system disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="21"/>
                    <count group_id="O5" value="18"/>
                    <count group_id="O6" value="23"/>
                    <count group_id="O7" value="17"/>
                    <count group_id="O8" value="13"/>
                    <count group_id="O9" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="7"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pregnancy, puerperium and perinatal conditions</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Psychiatric disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="8"/>
                    <count group_id="O7" value="13"/>
                    <count group_id="O8" value="12"/>
                    <count group_id="O9" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal and urinary disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="4"/>
                    <count group_id="O6" value="3"/>
                    <count group_id="O7" value="12"/>
                    <count group_id="O8" value="10"/>
                    <count group_id="O9" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="8"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reproductive system and breast disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="26"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="2"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="2"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Respiratory, thoracic and mediastinal disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="36"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="30"/>
                    <count group_id="O7" value="18"/>
                    <count group_id="O8" value="19"/>
                    <count group_id="O9" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin and subcutaneous tissue disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="15"/>
                    <count group_id="O6" value="13"/>
                    <count group_id="O7" value="8"/>
                    <count group_id="O8" value="5"/>
                    <count group_id="O9" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social circumstances</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vascular disorders</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</title>
        <description>Only the listing of plasma HIV RNA levels among all participants who seroconvert while on study are presented here. See outcome measure 12 for the listing of drug resistance test by arm.</description>
        <time_frame>From Enrollment to week 30 (end of self-administered dosing)</time_frame>
        <population>Below, each seroconverted participants' plasma HIV RNA levels at all visits with test results are presented</population>
        <group_list>
          <group group_id="O1">
            <title>Cape Town, South Africa, Seroconverted Participant #1</title>
            <description>#1 seroconverted participants in Cape Town, South Africa, not randomized</description>
          </group>
          <group group_id="O2">
            <title>Cape Town, South Africa, Seroconverted Participant #2</title>
            <description>#2 seroconverted participants in Cape Town, South Africa, not randomized</description>
          </group>
          <group group_id="O3">
            <title>Cape Town, South Africa, Seroconverted Participant #3</title>
            <description>#3 seroconverted participants in Cape Town, South Africa, not randomized</description>
          </group>
          <group group_id="O4">
            <title>Cape Town, South Africa, Seroconverted Participant #4</title>
            <description>#4 seroconverted participants in Cape Town, South Africa, daily arm</description>
          </group>
          <group group_id="O5">
            <title>Cape Town, South Africa, Seroconverted Participant #5</title>
            <description>#5 seroconverted participants in Cape Town, South Africa, time-driven arm</description>
          </group>
          <group group_id="O6">
            <title>Cape Town, South Africa, Seroconverted Participant #6</title>
            <description>#6 seroconverted participants in Cape Town, South Africa, time-driven arm</description>
          </group>
          <group group_id="O7">
            <title>Cape Town, South Africa, Seroconverted Participant #7</title>
            <description>#7 seroconverted participants in Cape Town, South Africa, event-driven arm</description>
          </group>
          <group group_id="O8">
            <title>Cape Town, South Africa, Seroconverted Participant #8</title>
            <description>#8 seroconverted participants in Cape Town, South Africa, event-driven arm</description>
          </group>
          <group group_id="O9">
            <title>Bangkok, Thailand, Seroconverted Participant #1</title>
            <description>#1 seroconverted participants in Bangkok, Thailand, not randomized</description>
          </group>
          <group group_id="O10">
            <title>Bangkok, Thailand, Seroconverted Participant #2</title>
            <description>#2 seroconverted participants in Bangkok, Thailand, not randomized</description>
          </group>
          <group group_id="O11">
            <title>Harlem, United States, Seroconverted Participant #1</title>
            <description>#1 seroconverted participants in Harlem, United States, not randomized</description>
          </group>
          <group group_id="O12">
            <title>Harlem, United States, Seroconverted Participant #2</title>
            <description>#2 seroconverted participants in Harlem, United States, daily arm</description>
          </group>
        </group_list>
        <measure>
          <title>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</title>
          <description>Only the listing of plasma HIV RNA levels among all participants who seroconvert while on study are presented here. See outcome measure 12 for the listing of drug resistance test by arm.</description>
          <population>Below, each seroconverted participants' plasma HIV RNA levels at all visits with test results are presented</population>
          <units>viral load</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="1"/>
                <count group_id="O11" value="1"/>
                <count group_id="O12" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Enrollment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="400"/>
                    <measurement group_id="O2" value="400"/>
                    <measurement group_id="O9" value="40"/>
                    <measurement group_id="O10" value="78450"/>
                    <measurement group_id="O11" value="400"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3460"/>
                    <measurement group_id="O2" value="3667690"/>
                    <measurement group_id="O9" value="749590"/>
                    <measurement group_id="O10" value="710"/>
                    <measurement group_id="O11" value="40900"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5732050"/>
                    <measurement group_id="O2" value="3938670"/>
                    <measurement group_id="O10" value="1570"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O4" value="400"/>
                    <measurement group_id="O9" value="92960"/>
                    <measurement group_id="O10" value="5070"/>
                    <measurement group_id="O11" value="83260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="416070"/>
                    <measurement group_id="O2" value="93040"/>
                    <measurement group_id="O4" value="400"/>
                    <measurement group_id="O9" value="1799950"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="93660"/>
                    <measurement group_id="O4" value="400"/>
                    <measurement group_id="O6" value="2100"/>
                    <measurement group_id="O9" value="119720"/>
                    <measurement group_id="O12" value="1567040"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="114520"/>
                    <measurement group_id="O4" value="650"/>
                    <measurement group_id="O6" value="3710"/>
                    <measurement group_id="O7" value="83010"/>
                    <measurement group_id="O9" value="127330"/>
                    <measurement group_id="O12" value="73030"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="178210"/>
                    <measurement group_id="O4" value="400"/>
                    <measurement group_id="O5" value="5887760"/>
                    <measurement group_id="O6" value="127480"/>
                    <measurement group_id="O7" value="136310"/>
                    <measurement group_id="O9" value="178070"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="89970"/>
                    <measurement group_id="O3" value="503950"/>
                    <measurement group_id="O6" value="220830"/>
                    <measurement group_id="O7" value="25020"/>
                    <measurement group_id="O8" value="400"/>
                    <measurement group_id="O9" value="96180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="35210"/>
                    <measurement group_id="O3" value="10910"/>
                    <measurement group_id="O6" value="193130"/>
                    <measurement group_id="O7" value="29390"/>
                    <measurement group_id="O8" value="400"/>
                    <measurement group_id="O9" value="36140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</title>
        <description>Only the listing of drug resistance test by arm among all participants who seroconvert while on study are presented here. See outcome measure 11 for the listing of plasma HIV RNA levels</description>
        <time_frame>From Enrollment to week 30 (end of self-administered dosing)</time_frame>
        <population>Below, each seroconverted participants' drug resistance test availability was presented. If the number analyzed equal to 0 then it means the resistance test was not done. When the number analyzed equal to 1 and outcome value is 0 then it means no drug resistance was detected, but if the outcome value is 1 then it means drug resistance was detected.</population>
        <group_list>
          <group group_id="O1">
            <title>Cape Town, South Africa, Seroconverted Participant #1</title>
            <description>#1 seroconverted participants in Cape Town, South Africa, not randomized</description>
          </group>
          <group group_id="O2">
            <title>Cape Town, South Africa, Seroconverted Participant #2</title>
            <description>#2 seroconverted participants in Cape Town, South Africa, not randomized</description>
          </group>
          <group group_id="O3">
            <title>Cape Town, South Africa, Seroconverted Participant #3</title>
            <description>#3 seroconverted participants in Cape Town, South Africa, not randomized</description>
          </group>
          <group group_id="O4">
            <title>Cape Town, South Africa, Seroconverted Participant #4</title>
            <description>#4 seroconverted participants in Cape Town, South Africa, daily arm</description>
          </group>
          <group group_id="O5">
            <title>Cape Town, South Africa, Seroconverted Participant #5</title>
            <description>#5 seroconverted participants in Cape Town, South Africa, time-driven arm</description>
          </group>
          <group group_id="O6">
            <title>Cape Town, South Africa, Seroconverted Participant #6</title>
            <description>#6 seroconverted participants in Cape Town, South Africa, time-driven arm</description>
          </group>
          <group group_id="O7">
            <title>Cape Town, South Africa, Seroconverted Participant #7</title>
            <description>#7 seroconverted participants in Cape Town, South Africa, event-driven arm</description>
          </group>
          <group group_id="O8">
            <title>Cape Town, South Africa, Seroconverted Participant #8</title>
            <description>#8 seroconverted participants in Cape Town, South Africa, event-driven arm</description>
          </group>
          <group group_id="O9">
            <title>Bangkok, Thailand, Seroconverted Participant #1</title>
            <description>#1 seroconverted participants in Bangkok, Thailand, not randomized</description>
          </group>
          <group group_id="O10">
            <title>Bangkok, Thailand, Seroconverted Participant #2</title>
            <description>#2 seroconverted participants in Bangkok, Thailand, not randomized</description>
          </group>
          <group group_id="O11">
            <title>Harlem, United States, Seroconverted Participant #1</title>
            <description>#1 seroconverted participants in Harlem, United States, not randomized</description>
          </group>
          <group group_id="O12">
            <title>Harlem, United States, Seroconverted Participant #2</title>
            <description>#2 seroconverted participants in Harlem, United States, daily arm</description>
          </group>
        </group_list>
        <measure>
          <title>A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on Study</title>
          <description>Only the listing of drug resistance test by arm among all participants who seroconvert while on study are presented here. See outcome measure 11 for the listing of plasma HIV RNA levels</description>
          <population>Below, each seroconverted participants' drug resistance test availability was presented. If the number analyzed equal to 0 then it means the resistance test was not done. When the number analyzed equal to 1 and outcome value is 0 then it means no drug resistance was detected, but if the outcome value is 1 then it means drug resistance was detected.</population>
          <units>viral load</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
                <count group_id="O10" value="1"/>
                <count group_id="O11" value="1"/>
                <count group_id="O12" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Enrollment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="1"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O12" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 22</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="1"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                    <count group_id="O12" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From week 6 (randomization week) to week 30 (end of self-administered dosing)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Daily Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E2">
          <title>Time-driven Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E3">
          <title>Event-driven Dosing, Cape Town</title>
          <description>Cape Town participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E4">
          <title>Daily Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E5">
          <title>Time-driven Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E6">
          <title>Event-driven Dosing, Bangkok</title>
          <description>Bangkok participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E7">
          <title>Daily Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF daily.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E8">
          <title>Time-driven Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF twice weekly with a post-exposure dose.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
        <group group_id="E9">
          <title>Event-driven Dosing, Harlem</title>
          <description>Harlem participants will receive oral FTC/TDF before and after a potential exposure to HIV infection.
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): A fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, two nucleoside reverse transcriptase inhibitors.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acute tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stab wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Ectopic pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="59" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="58" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="59" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="58" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="53" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="55" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="54" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Motion sickness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Otorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Episcleritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eyelid oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pterygium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal tenderness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="12" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="12" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemorrhoids thrombosed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lip dry</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Feeling hot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hangover</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acute tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Body tinea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chlamydial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear infection fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eyelid infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Genital herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gonorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Herpes virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lice infestation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="26" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="34" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="27" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sexually transmitted disease</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Shigella infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Syphilis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tinea faciei</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tinea pedis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tinea versicolour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urethritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urethritis chlamydial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urethritis gonococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingival injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Penis injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Periorbital haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post procedural constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post procedural diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural dizziness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stab wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sunburn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Trench foot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood phosphorus decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood pressure diastolic increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood sodium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glucose urine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neutrophil count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Protein urine present</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>White blood cell count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal loss of weight</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abnormal weight gain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Increased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Joint stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Oral papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="17" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="14" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post-traumatic headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Ectopic pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal dreams</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Alcoholic hangover</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Libido decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Loss of libido</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mood swings</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nightmare</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glycosuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urethral pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urethritis noninfective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urine odour abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast enlargement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Breast tenderness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Coital bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ejaculation delayed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ejaculation disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ejaculation failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Galactorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Genital rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Genital ulceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Menometrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nipple pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Penile discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Penis disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pruritus genital</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Scrotal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dry throat</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="22" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hidradenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ingrown hair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intertrigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Miliaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nail discolouration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nail disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Papule</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Seborrhoeic dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin discolouration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urticaria papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Victim of sexual abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>All study abstracts and publications are subject to HPTN Publication and Public Information Policies and Clinical Trial Agreements between NIAID (DAIDS) and company collaborators. The publication or other disclosure can be delayed for up to thirty additional business days for manuscripts and five business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Maoji Li (Statistical Research Associate)</name_or_title>
      <organization>Fred Hutchinson Cancer Research Center</organization>
      <phone>2066676035</phone>
      <email>mli2@fredhutch.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

